Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125218) titled 'The detection of hemoglobinopathy variants by single-molecular long read sequencing: a multi-center study' on May 22.
Study Type: Diagnostic test
Study Design:
Cross-sectional
Primary Sponsor: The First People's Hospital of Yunnan Province
Condition:
Thalassemia
Intervention:
Gold Standard:thalassemia genetic mutation testing:Gap-polymerase chain reaction (Gap-PCR), Dideoxy chain termination sequencing (Sanger sequencing) and so on
Complete blood count and hemoglobin electrophoresis testing
Recruitment Status: Not Recruiting
Phase: Diagnostic New Technique Clincal Study
Date of First Enrollment: 2025-...